Skip to main content

. 1992 Apr;55(4):333–334. doi: 10.1136/jnnp.55.4.333

Ceftazidime encephalopathy: absence status and toxic hallucinations.

G D Jackson, S F Berkovic

PMCID: PMC489059 PMID: 1583528

333

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Andermann F., Robb J. P. Absence status. A reappraisal following review of thirty-eight patients. Epilepsia. 1972 Jan;13(1):177–187. doi: 10.1111/j.1528-1157.1972.tb04565.x. [DOI] [PubMed] [Google Scholar]
Berkovic S. F., Andermann F., Guberman A., Hipola D., Bladin P. F. Valproate prevents the recurrence of absence status. Neurology. 1989 Oct;39(10):1294–1297. doi: 10.1212/wnl.39.10.1294. [DOI] [PubMed] [Google Scholar]
Douglas M. A., Quandt C. M., Stanley D. A. Ceftazidime-induced encephalopathy in a patient with renal impairment. Arch Neurol. 1988 Sep;45(9):936–937. doi: 10.1001/archneur.1988.00520330010002. [DOI] [PubMed] [Google Scholar]
Feinberg W. M., Rapcsak S. Z. 'Peduncular hallucinosis' following paramedian thalamic infarction. Neurology. 1989 Nov;39(11):1535–1536. doi: 10.1212/wnl.39.11.1535. [DOI] [PubMed] [Google Scholar]
McKee A. C., Levine D. N., Kowall N. W., Richardson E. P., Jr Peduncular hallucinosis associated with isolated infarction of the substantia nigra pars reticulata. Ann Neurol. 1990 May;27(5):500–504. doi: 10.1002/ana.410270508. [DOI] [PubMed] [Google Scholar]
al-Zahawi M. F., Sprott M. S., Hendrick D. J. Hallucinations in association with ceftazidime. BMJ. 1988 Oct 1;297(6652):858–858. doi: 10.1136/bmj.297.6652.858-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES